KFDA seriously concerns about sales of Viagra.

Published: 1999-06-03 17:18:00

Updated: 1999-06-03 17:18:00

It is anticipated for Viagra health registration to be approved in June after due completion of the local clinical phase III study. However, the KFDA held a meeting of the Central Pharmaceutical Evaluation Committee on May 27 and discussed clinical study results conducted at 6 hospitals including...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK